Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 636 of 6351
-
Breathing technique may tune the nervous system to improve blood sugar
Disease control Recruiting nowApproximately 20% of adults have prediabetes in Germany. Prediabetes is defined as a condition with glucose levels outside the normal range but not yet meeting the criteria for type 2 diabetes. The pathogenesis of prediabetes, as well as of type 2 diabetes, involves whole-body in…
Sponsor: Johannes Gutenberg University Mainz • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New monthly shot aims to keep schizophrenia symptoms at bay
Disease control Recruiting nowThe purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.
Phase 3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for transplant patients: drug combo may tame deadly immune attack
Disease control Recruiting nowThis clinical trial will study ruxolitinib-based treatment of acute graft-versus-host-disease (GVHD) that developed following allogeneic hematopoietic cell transplant. Acute GVHD occurs when donor cells attack the healthy tissue of the body. The most common symptoms are skin rash…
Phase 2 • Sponsor: John Levine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New ultrasound dye could stop unnecessary emergency surgeries for ovarian torsion
Diagnosis Recruiting nowAdnexal torsion is the rotation of the ovary around its vascular axis resulting, in the absence of treatment, ischemia that can lead to peritonitis by necrosis or impaired fertility. It is a gynecological emergency affecting 3% of women of childbearing age, including from adolesc…
Phase 3 • Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Genome-First approach could speed up rare disease diagnoses for kids
Knowledge-focused By invitation onlyIndividually rare genetic diseases are collectively common, and affect many Canadian families. Making the right diagnosis is both important and challenging. Healthcare providers and families often remain in the dark for too long, limited by the scope and speed of current genetic …
Sponsor: The Hospital for Sick Children • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Radioactive bullet targets Hard-to-Treat prostate cancer
Disease control Recruiting nowA Phase I/IIa clinical trial to evaluate the safety, tolerability, pharmacokinetics, radiation dosimetry, and preliminary efficacy of INR102 injection in patients with prostate cancer.
Phase 1/2 • Sponsor: Yunhe Pharmaceutical (Tianjin) Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New study aims to boost HIV prevention in underserved rural communities
Prevention By invitation onlyDuring this 5-year study, stepped-care adaptive interventions will be deployed in three rural syringe service programs in a Sequential Multiple Assignment Randomized Trial (SMART) design to test the optimal intervention pathways for HIV PrEP uptake, defined as PrEP initiation (me…
Sponsor: Hilary L Surratt, PhD • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
New injection aims to ease Post-Surgery pain without Morphine's downsides
Symptom relief OngoingThe primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following abdominal surgery.
Phase 3 • Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New catheter lock aims to stop deadly infections in home nutrition patients
Disease control Recruiting nowThis is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult participants receiving home Total Parenteral Nutrition (TPN) via Central Venous Catheter (CVC) compared with heparin.
Phase 3 • Sponsor: CorMedix Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New combo therapy targets aggressive lung cancer transformation
Disease control Recruiting nowThe primary treatment option for non-small cell lung cancer (NSCLC) adenocarcinoma (ADC) with activating epidermal growth factor receptor (EGFR) mutation is EGFR tyrosine kinase inhibitor (TKI). After a certain period of treatment with EGFR TKI, acquired resistance emerges most f…
Phase 2 • Sponsor: Se-Hoon Lee • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThe researchers are doing this study is to find out if lower doses (given in fewer treatments over a shorter period of time) of radiation therapy in combination with standard-of-care chemotherapy is an effective treatment for people with Human Papilloma Virus (HPV)-positive throa…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Smart drug missiles take aim at Hard-to-Treat lung cancer
Disease control Recruiting nowResearchers are looking for new ways to treat metastatic nonsquamous non-small cell lung cancer (NSCLC) that has been treated before. Metastatic means the cancer has spread to other parts of the body. Nonsquamous means the cancer did not start in squamous cells, which are flat ce…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
One-Patient trial hopes to fix rare nerve disease at its genetic root
Disease control OngoingThis is an 'N of 1', open-label, single center study to evaluate the safety of therapy with VCA-894A, an ASO designed to rescue and restore the activity of IGHMBP2, when administered by intrathecal injection.
Phase 1/2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New combo aims to cut hormone therapy in prostate cancer
Disease control Recruiting nowThe goal of this clinical trial is to is to investigate if it is possible to lower the chance of cancer reoccurrence and also preserve quality of life by using the drug Pluvicto instead of androgen-deprivation therapy to the usual radiation therapy for advanced local prostate can…
Phase 1/2 • Sponsor: Angela Y. Jia, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New CMV prevention drug could be safer for kidney transplant patients
Prevention Recruiting nowthe existing anti-CMV drugs mainly include valganciclovir, ganciclovir and foscarnet sodium, all of which act on DNA polymerase (pUL54), making them prone to cross resistance. DNA synthesis in normal cell is also catalyzed by DNA polymerase, which can also inhibit normal cell pro…
Phase 4 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Could a simple drug stop deadly organ failure after surgery?
Prevention OngoingMajor abdominal surgeries (e.g., gastrectomy, pancreatectomy, colectomy) carry a high risk of life-threatening postoperative complications, including multiorgan disfunction syndrome (MODS), acute kidney injur (AKI), miocardial injury after non-cardiac surgery (MINS) and severe in…
Phase 3 • Sponsor: Botkin Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
New hope for Hard-to-Treat colorectal cancer: drug combo enters Mid-Stage trial
Disease control Recruiting nowThis is a Phase II trial designed to determine the optimal dose and evaluate the effectiveness of TL938 and trastuzumab in treating patients with HER2+ colorectal cancer that has metastasized or recurred and is inoperable.
Phase 2 • Sponsor: Suzhou Teligene Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for severe aplastic anemia: bone marrow transplant from partial matches shows promise
Disease control Recruiting nowBMT CTN 2207 will investigate the use of marrow transplantation for treatment of severe aplastic anemia that has not previously been treated.
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can cutting arginine from the diet starve solid tumors?
Disease control CompletedThis is a phase I single-arm clinical study conducted by West China Hospital of Sichuan University. The research duration is from March 2025 to March 2027, aiming to evaluate the safety and efficacy of arginine-restricted diet (-Arg diet) in patients with solid tumors. A total of…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 10, 2026 07:00 UTC
-
Can a bone marrow injection save young hips after fracture?
Disease control Recruiting nowObjectives: * Primary objective : * To investigate the predisposing factors for femoral neck fractures, including age, sex, and associated comorbidities. * To investigate the complications associated with intracapsular femoral neck fractures, particularly in young patients. * To…
Sponsor: Yaser Alkanash • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC